Heterocyclic Compounds, 1-Ring
"Heterocyclic Compounds, 1-Ring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic compounds that contain a ring structure made up of carbon and one or more additional elements such as nitrogen and oxygen.
Descriptor ID |
D006573
|
MeSH Number(s) |
D03.383
|
Concept/Terms |
Heterocyclic Compounds, 1-Ring- Heterocyclic Compounds, 1-Ring
- 1-Ring Heterocyclic Compounds
- Heterocyclic Compounds, 1 Ring
- Heterocyclic Cpds, 1-Ring
- 1-Ring Heterocyclic Cpds
- Heterocyclic Cpds, 1 Ring
|
Below are MeSH descriptors whose meaning is more general than "Heterocyclic Compounds, 1-Ring".
Below are MeSH descriptors whose meaning is more specific than "Heterocyclic Compounds, 1-Ring".
This graph shows the total number of publications written about "Heterocyclic Compounds, 1-Ring" by people in this website by year, and whether "Heterocyclic Compounds, 1-Ring" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2012 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
2021 | 0 | 1 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heterocyclic Compounds, 1-Ring" by people in Profiles.
-
Fanti S, Briganti A, Emmett L, Fizazi K, Gillessen S, Goffin K, Hadaschik BA, Herrmann K, Kunikowska J, Maurer T, MacLennan S, Mottet N, Murphy DG, Oprea-Lager DE, O'Sullivan JM, Oyen WJG, Rouvi?re O, Sartor O, Stenzl A, Van Poppel H, Walz J, Witjes W, Bjartell A. EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy. Eur Urol Oncol. 2022 10; 5(5):530-536.
-
Manafi-Farid R, Harsini S, Saidi B, Ahmadzadehfar H, Herrmann K, Briganti A, Walz J, Beheshti M. Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review. Eur J Nucl Med Mol Imaging. 2021 11; 48(12):4028-4041.
-
Silva AF, Oliveira VX, Silva LS, Pinheiro AAS, Ciscato LFML. Antiplasmodial activity of alkyl-substituted 1,2-dioxetanes against Plasmodium falciparum. Bioorg Med Chem Lett. 2016 10 15; 26(20):5007-5008.
-
Larimer BM, Thomas WD, Smith GP, Deutscher SL. Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display. Mol Imaging Biol. 2014 Aug; 16(4):449-58.
-
Liu X, Cheng D, Gray BD, Wang Y, Akalin A, Rusckowski M, Pak KY, Hnatowich DJ. Radiolabeled Zn-DPA as a potential infection imaging agent. Nucl Med Biol. 2012 Jul; 39(5):709-14.
-
Zhang X, Jing X, Liu T, Han G, Li H, Duan C. Dual-functional gadolinium-based copper(II) probe for selective magnetic resonance imaging and fluorescence sensing. Inorg Chem. 2012 Feb 20; 51(4):2325-31.
-
Liang M, Liu X, Cheng D, Liu G, Dou S, Wang Y, Rusckowski M, Hnatowich DJ. Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle. Bioconjug Chem. 2010 Jul 21; 21(7):1385-8.
-
Weissleder R, Bogdanov A, Tung CH, Weinmann HJ. Size optimization of synthetic graft copolymers for in vivo angiogenesis imaging. Bioconjug Chem. 2001 Mar-Apr; 12(2):213-9.